Sustained prognostic value of proadrenomedulin in severe sepsis and septic shock

Overview of attention for article published in Intensive Care Medicine Experimental, October 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

patent: 6 patents

Readers on

mendeley: 2 Mendeley

Summary Patents

So far, Altmetric has seen 6 patents that reference this research output.

PROADM AS MARKER INDICATING AN ADVERSE EVENT

Application EP-4220175-A1

European Patent Office

PROADM AS MARKER INDICATING AN ADVERSE EVENT

Grant EP-3577465-B1

European Patent Office

DIAGNOSIS OR PROGNOSIS OF POSTSURGICAL ADVERSE EVENTS

Application WO-2020169819-A1

World Intellectual Property Organisation (WIPO)

PRO-ADM FOR PROGNOSING THE RISK OF A MEDICAL CONDITION REQUIRING HOSPITALIZATION IN…

Application WO-2020030745-A1

World Intellectual Property Organisation (WIPO)

PRO-ADM FOR PROGNOSING THE RISK OF A MEDICAL CONDITION REQUIRING HOSPITALIZATION IN…

Application EP-3608673-A1

European Patent Office

PROADM AS MARKER INDICATING AN ADVERSE EVENT

Application WO-2018141840-A1

World Intellectual Property Organisation (WIPO)